ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 088,24
0,89%
Dow Jones
38 239,66
0,40%
DAX
18 161,01
1,32%
Brent Oil
88,165
0,00%
Bitcoin
62 997,69
-1,16%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Panacea Acquisition Corp (NUVB)

  7. Panacea Acquisition Corp (NUVB) Actualités

NUVB Panacea Acquisition Corp

2,75
0,13 (4,96%)
27 Avr 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Panacea Acquisition Corp NUVB NYSE Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,13 4,96% 2,75 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
2,63 2,61 2,76 2,68 2,62
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202416:01BWNuvation Bio to Present Updated Data on Taletrectinib, a..
10/4/202422:01BWNuvation Bio Completes Acquisition of AnHeart Therapeutics
28/3/202413:00BWNuvation Bio Announces Appointment of Colleen Sjogren as..
25/3/202412:00BWNuvation Bio to Acquire AnHeart Therapeutics in All-Stock..
14/3/202421:05BWNuvation Bio Doses First Patient in Phase 1/2 Study of..
04/3/202423:30EDGAR2Form S-8 - Securities to be offered to employees in employee..
04/3/202423:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/3/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202423:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:48EDGAR2Form 8-K - Current report
29/2/202422:01BWNuvation Bio Reports Fourth Quarter and Full Year 2023..
10/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/1/202422:58DJNNuvation Bio Gets New Drug Application Clearance From FDA..
08/1/202422:17EDGAR2Form 8-K - Current report
08/1/202422:10BWNuvation Bio Announces Appointment of Dr. Robert Mashal to..
08/1/202422:05BWNuvation Bio Announces FDA Clearance of Investigational New..
14/12/202322:02EDGAR2Form 8-K - Current report
27/11/202322:09EDGAR2Form 3 - Initial statement of beneficial ownership of..
27/11/202322:01EDGAR2Form 8-K - Current report
13/11/202322:11EDGAR2Form 8-K - Current report
13/11/202322:05BWNuvation Bio Announces Departure of Chief Financial Officer
02/11/202321:23EDGAR2Form 8-K - Current report
02/11/202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202321:10BWNuvation Bio Reports Third Quarter 2023 Financial Results..
03/8/202323:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202322:17EDGAR2Form 8-K - Current report
03/8/202322:10BWNuvation Bio Reports Second Quarter 2023 Financial Results..
01/6/202322:05BWNuvation Bio Announces Formation of Oncology-Focused..
04/5/202322:05BWNuvation Bio Reports First Quarter 2023 Financial Results..

Dernières Valeurs Consultées

NYSE
NUVB
Panacea Acquisition
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés